A recent study focusing on Eomes+CD4+ CTLs has expanded and documented their roles in anti-tumor immunity and pathological responses in inflamed conditions such as rheumatoid arthritis and multiple sclerosis (24, 37). This evidence concerns the gene CD4 and multiple sclerosis.